1. Executive Summary
1.1. Global OTC Pet Medication Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global OTC Pet Medication Market Outlook, 2018 - 2031
3.1. Global OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Fleas & Ticks
3.1.1.2. Pain Relief & Arthritis
3.1.1.3. Dewormers
3.1.1.4. Others
3.2. Global OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Dogs
3.2.1.2. Cats
3.2.1.3. Birds
3.2.1.4. Fish & Reptiles
3.2.1.5. Small Pets
3.2.1.6. Others
3.3. Global OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Chewable & Tablets
3.3.1.2. Capsules & Ointment
3.3.1.3. Sprays
3.3.1.4. Others
3.4. Global OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Pet Specialty Stores
3.4.1.2. Veterinary Clinics
3.4.1.3. Drug & Pharmacy Stores
3.4.1.4. Online Retail
3.4.1.5. Others
3.5. Global OTC Pet Medication Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America OTC Pet Medication Market Outlook, 2018 - 2031
4.1. North America OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Fleas & Ticks
4.1.1.2. Pain Relief & Arthritis
4.1.1.3. Dewormers
4.1.1.4. Others
4.2. North America OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Dogs
4.2.1.2. Cats
4.2.1.3. Birds
4.2.1.4. Fish & Reptiles
4.2.1.5. Small Pets
4.2.1.6. Others
4.3. North America OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Chewable & Tablets
4.3.1.2. Capsules & Ointment
4.3.1.3. Sprays
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Pet Specialty Stores
4.4.1.2. Veterinary Clinics
4.4.1.3. Drug & Pharmacy Stores
4.4.1.4. Online Retail
4.4.1.5. Others
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe OTC Pet Medication Market Outlook, 2018 - 2031
5.1. Europe OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Fleas & Ticks
5.1.1.2. Pain Relief & Arthritis
5.1.1.3. Dewormers
5.1.1.4. Others
5.2. Europe OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Dogs
5.2.1.2. Cats
5.2.1.3. Birds
5.2.1.4. Fish & Reptiles
5.2.1.5. Small Pets
5.2.1.6. Others
5.3. Europe OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Chewable & Tablets
5.3.1.2. Capsules & Ointment
5.3.1.3. Sprays
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pet Specialty Stores
5.4.1.2. Veterinary Clinics
5.4.1.3. Drug & Pharmacy Stores
5.4.1.4. Online Retail
5.4.1.5. Others
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.9. France OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.10. France OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.11. France OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.12. France OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific OTC Pet Medication Market Outlook, 2018 - 2031
6.1. Asia Pacific OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Fleas & Ticks
6.1.1.2. Pain Relief & Arthritis
6.1.1.3. Dewormers
6.1.1.4. Others
6.2. Asia Pacific OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Dogs
6.2.1.2. Cats
6.2.1.3. Birds
6.2.1.4. Fish & Reptiles
6.2.1.5. Small Pets
6.2.1.6. Others
6.3. Asia Pacific OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Chewable & Tablets
6.3.1.2. Capsules & Ointment
6.3.1.3. Sprays
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pet Specialty Stores
6.4.1.2. Veterinary Clinics
6.4.1.3. Drug & Pharmacy Stores
6.4.1.4. Online Retail
6.4.1.5. Others
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.2. China OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.3. China OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.4. China OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.1.13. India OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.14. India OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.15. India OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.16. India OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America OTC Pet Medication Market Outlook, 2018 - 2031
7.1. Latin America OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Fleas & Ticks
7.1.1.2. Pain Relief & Arthritis
7.1.1.3. Dewormers
7.1.1.4. Others
7.2. Latin America OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
7.2.1.1. Dogs
7.2.1.2. Cats
7.2.1.3. Birds
7.2.1.4. Fish & Reptiles
7.2.1.5. Small Pets
7.2.1.6. Others
7.3. Latin America OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Chewable & Tablets
7.3.1.2. Capsules & Ointment
7.3.1.3. Sprays
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
7.4.1.1. Pet Specialty Stores
7.4.1.2. Veterinary Clinics
7.4.1.3. Drug & Pharmacy Stores
7.4.1.4. Online Retail
7.4.1.5. Others
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa OTC Pet Medication Market Outlook, 2018 - 2031
8.1. Middle East & Africa OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Fleas & Ticks
8.1.1.2. Pain Relief & Arthritis
8.1.1.3. Dewormers
8.1.1.4. Others
8.2. Middle East & Africa OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Dogs
8.2.1.2. Cats
8.2.1.3. Birds
8.2.1.4. Fish & Reptiles
8.2.1.5. Small Pets
8.2.1.6. Others
8.3. Middle East & Africa OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Chewable & Tablets
8.3.1.2. Capsules & Ointment
8.3.1.3. Sprays
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pet Specialty Stores
8.4.1.2. Veterinary Clinics
8.4.1.3. Drug & Pharmacy Stores
8.4.1.4. Online Retail
8.4.1.5. Others
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Type vs by Pet Type Heat map
9.2. Manufacturer vs by Pet Type Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Bayer Companion Animal
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Boehringer Ingelheim
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Animal Health
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Ceva Sante Animate
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Merck Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Zoetis Inc
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Elanco
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Virbac SA
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Vetoquinol SA
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Frontline
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Zymox
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. ChloraSeb
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Sulfox
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Adequan
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Dechra Pharmaceuticals PLC
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Nutramax Laboratories, Inc.
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations